Gustave Roussy, Cancer Campus, Grand Paris: Neoplasm Metastasis trials
The registry lists 10 Neoplasm Metastasis studies with Gustave Roussy, Cancer Campus, Grand Paris as lead sponsor. 3 are open to participants now and 0 have results posted.
Phase 2 7Phase 3 1No phase 3(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Study Investigating ASP3082 in Patients With Metastatic/Locally Advanced Non-small-cell Lung Cancer (NSCLC) and Pancreatic Ductal Adenocarcinoma (PDAC), With Biomarker Analysis to Characterize Response/ResistanceRecruitingNCT07483983Phase 2
- Study Investigating Tarlatamab (AMG 757) in Patients With Metastatic/Locally Advanced Small-Cell Lung Cancer (SCLC) and Other Poorly Differentiated Neuroendocrine Carcinomas (NECs), With Biomarker Analysis to Characterize Response/Resistance (UNLOCK TARLATAMAB)RecruitingNCT07016230Phase 2
- Implementing Precision Medicine in cOmmunity HospiTALsRecruitingNCT05283044Not applicable
- Measurement and Characterization of Circulating Endothelial Cells or Circulating Tumor Cells or Circulating DNA in Adult Patients With Metastatic CancerStatus unknownNCT02666612Not applicable
- Postoperative Hepatic Arterial Chemotherapy in High-risk Patients as Adjuvant Treatment After Resection of Colorectal Liver MetastasesCompletedNCT02494973Phase 2/3
- Efficacy of Radium 223 in Radioactive Iodine Refractory Bone Metastases From Differentiated Thyroid CancerCompletedNCT02390934Phase 2
- Trial of Ipilimumab After Isolated Limb Perfusion, in Patients With Metastases MelanomaCompletedNCT02094391Phase 2
- A Study to Select Rational Therapeutics Based on the Analysis of Matched Tumor and Normal Biopsies in Subjects With Advanced MalignanciesCompletedNCT01856296Not applicable
- Leucovorin, Fluorouracil, Cetuximab, and Oxaliplatin in Treating Patients With Stage IV Colorectal Cancer and Liver Metastases That Cannot Be Removed by SurgeryCompletedNCT00544349Phase 2
- Radiofrequency Ablation of Lung TumorsCompletedNCT00180856Phase 2